Radiopharmaceutical therapies are revolutionizing cancer treatment, offering targeted approaches that improve patient outcomes. However, the complexities of personalized dosimetry and treatment planning present significant challenges for hospitals and health systems, especially amid staff shortages and inefficient workflows.

 

In this webinar, experts from Bridge Oncology and TeleDaaS will discuss innovative solutions to these challenges. We'll delve into how TeleDaaS is expanding its Dosimetry-as-a-Service model beyond clinical trials to provide hospitals with precision-based dosimetry analysis and treatment plans for liver cancer patients treated with Yttrium-90 (Y90) therapies.